Senseonics Holdings, Inc., a medical tech company specializing in implantable glucose monitoring systems, has closed a public offering raising $92 million. The company sold 10.4 million common shares, including 2.4 million additional shares from the underwriters’ option, plus 8 million pre-funded warrants. The proceeds will support the development and commercialization of their long-term glucose monitoring products. This financing strengthens Senseonics' position in the diabetes care market as it advances its technology and expands its offerings.
Moment Factory and Mitsui Fudosan have formed a long-term strategic partnership to develop large-scale immersive fan experiences, including a new Pokémon attraction set to launch in Europe in spring 2027. This collaboration combines Moment Factory's ...
FCCE, the majority shareholder of Installux, has agreed to acquire 6.38% of Installux shares from Amiral Gestion at €500 per share, totaling €8.93 million. Following this acquisition, FCCE will hold 87.45% of Installux's capital and voting rights. FC...
Toll Brothers announced a new luxury home community called Toll Brothers at West Park in Ashburn, Virginia, located in the Brambleton neighborhood. The community will feature modern single-family homes with 3 to 5 bedrooms, up to 3,300 square feet, a...
The Nasdaq 100 index surpassed 30,000 points during Tuesday's session, led by a strong rally in semiconductor stocks, especially Micron Technology which surged 18%. This rally was fueled by rising expectations for AI-related spending, with UBS raisin...
Hyliion's stock surged to a 52-week high following its partnership with the U.S. Navy to test its KARNO power system on an autonomous naval vessel. The company reported better-than-expected Q1 results, with revenue of $2.83 million and a smaller loss...
